Roliten
✅ Reduce frecvența urinară
✅ Controls urge incontinence
✅ Relieves bladder spasms
✅ Îmbunătățește fluxul urinar
✅ Îmbunătățește controlul vezical
Roliten contains Tolterodine.
✓ Verificat medical de Morgan Ellis — Cercetător farmaceutic · 8 ani de experiență · Ultima recenzie: mai 2026
Quick Answer — What is Roliten?
Roliten conține tartrat de tolterodină — a competitive muscarinic acetylcholine receptor antagonist used to treat vezică hiperactivă (OAB) with urgency, frequency, and urge incontinence. Available as 1 mg immediate-release tablets. Standard dose: 2 mg twice daily (or 1 mg twice daily in renal/hepatic impairment or with strong CYP3A4 inhibitors). For convenient once-daily dosing with smoother side-effect profile, see the extended-release formulation (Terol LA). Tolterodine is generally better tolerated than oxybutynin — less dry mouth, less constipation, and lower CNS penetration. Use with caution in adults aged 65+ — the 2023 American Geriatrics Society Beers Criteria classifies all anticholinergic OAB drugs as “potentially inappropriate” in older adults due to cumulative anticholinergic burden. Mirabegron (Mirago) is the preferred first-line OAB drug in this population.
📦 Fiecare comandă este acoperită de politica noastră de Politica noastră de Reexpediere Garantată — dacă coletul dumneavoastră nu sosește în 20 de zile lucrătoare, îl relivrăm.
De ce să comanzi de la MedsBase
Fiecare lot este procurat de la un producător certificat WHO-GMP. Comenzile sunt expediate în ambalaje simple, fără marcă, de la partenerii noștri de onorare și acoperite de Politica noastră de Reexpediere Garantată: dacă un colet nu ajunge în 20 de zile lucrătoare, trimitem gratuit o nouă comandă, fără întrebări.
What is Roliten?
Roliten is a brand of tolterodine tartrate 1 mg immediate-release tablets. Tolterodine is one of the most-prescribed antimuscarinic OAB drugs worldwide. Internationally branded as Detrol / Detrol LA (US), Detrusitol / Detrusitol XL (UK / EU). Pack sizes available at MedsBase: 30, 60, 90 or 180 tablets/capsules.
How tolterodine works
Tolterodine is a competitive antagonist at M2 and M3 muscarinic acetylcholine receptors. Bladder M3 blockade reduces parasympathetic-driven detrusor contractions during the filling phase — decreasing urgency and incontinence episodes and increasing functional bladder capacity.
Comparativ cu oxybutynin, tolterodine has somewhat better selectivity for bladder vs salivary-gland muscarinic receptors, lower CNS penetration, and a more favourable side-effect profile — particularly less severe dry mouth. Both are still anticholinergics with the standard class warnings about elderly use.
Tolterodine is metabolised by CYP2D6 to an active metabolite (5-hydroxymethyl tolterodine) which contributes substantially to clinical effect. About 5-10% of the population are CYP2D6 “poor metabolisers” who form less of the metabolite and need dose adjustment.
When tolterodine is used
- Overactive bladder syndrome (OAB) with urgency, frequency, urge incontinence, nocturia — the licensed indication
- Neurogenic detrusor overactivity — selected adult cases (multiple sclerosis, spinal cord injury)
- Patients intolerant of oxybutynin — tolterodine is a common second-choice antimuscarinic with slightly better tolerability
- OAB combination therapy with mirabegron — for refractory OAB symptoms in patients who tolerate but don’t fully respond to either alone
Dozaj și mod de administrare
- Standard adult dose: 2 mg twice daily
- Reduced dose 1 mg twice daily for: significant renal impairment (eGFR <30), moderate hepatic impairment, concurrent strong CYP3A4 inhibitors, or patients poorly tolerating 2 mg twice daily
- Take with or without food, with water. Swallow tablets whole.
- For more convenient once-daily dosing, ask your doctor about Terol LA (extended-release tolterodine 2 mg / 4 mg capsules)
- Effect develops over 4-8 weeks. If no benefit by 8 weeks, switch to a different agent.
Efecte secundare și siguranță
- Frecvente (1 din 10): dry mouth (less severe than oxybutynin but still the leading reason for discontinuation), constipation, dry eyes, blurred vision, headache, dyspepsia, fatigue
- Mai puțin frecvente: drowsiness, dizziness, peripheral oedema, urinary retention or hesitancy, dry skin, weight gain
- Mai puțin frecvente, dar importante: confusion, hallucinations (especially in elderly), QT prolongation (caution if QT-prolonging co-medications)
- Rare dar grave: acute angle-closure glaucoma, severe constipation / paralytic ileus, urinary retention, anaphylaxis, angioedema
Anticholinergic burden & the elderly
Tolterodine has somewhat lower CNS penetration than oxybutynin and is generally considered the better-tolerated of the two anticholinergic OAB drugs in older adults — but it is still classified as “potentially inappropriate” in the Beers Criteria and should be used cautiously and at the lowest effective dose. Mirabegron remains the preferred first-line OAB drug in adults aged 65+ when affordable and not contraindicated by hypertension.
Contraindicații și avertizări
Do not take tolterodine if you have:
- Untreated narrow-angle glaucoma
- Urinary retention or significant bladder outlet obstruction
- Severe gastrointestinal motility disorders (paralytic ileus, severe ulcerative colitis, toxic megacolon)
- Miastenie gravis
- Insuficiență hepatică severă
- Hypersensitivity to tolterodine or fesoterodine (its prodrug)
Folosiți cu precauție dacă aveți: elderly age (see above), benign prostatic hyperplasia (urinary retention risk), reflux oesophagitis, autonomic neuropathy, congenital or acquired QT prolongation, coronary artery disease.
Interacțiuni medicamentoase
- Inhibitori puternici ai CYP3A4 (ketoconazole, itraconazole, ritonavir, clarithromycin, indinavir) — sharply increase tolterodine levels; reduce dose to 1 mg BD (IR) or 2 mg OD (LA)
- Alte anticolinergice — additive effects; minimise stacking (diphenhydramine, hydroxyzine, amitriptyline, paroxetine, quetiapine, hyoscyamine, oxybutynin)
- Cholinesterase inhibitors (donepezil, rivastigmine, galantamine for dementia) — opposing mechanisms; co-prescribing both is irrational
- Medicamente care prelungesc intervalul QT (antiaritmice de clasă Ia/III, unele antipsihotice, antibiotice din clasa chinolonelor) — risc teoretic aditiv
- CYP2D6 substrate medications — tolterodine is metabolised by CYP2D6, so poor metabolisers (5-10% of population) have higher exposure
How tolterodine compares
| Medicament | Trăsătură notabilă |
|---|---|
| Oxybutynin | Older, cheaper; highest dry mouth + cognitive risk |
| Tolterodine IR / LA | Better tolerated than oxybutynin; LA gives once-daily dosing |
| Solifenacin / darifenacin | More M3-selective; slightly less dry mouth |
| Mirabegron | β3 agonist — preferred first-line in 65+; no anticholinergic burden |
| Flavoxate (Urispas) | Antispasmodic; useful for urinary spasm post-procedure |
Depozitare și termen de valabilitate
Store Roliten below 25°C in the original blister pack. Protect from moisture and light. Keep out of reach of children. Do not use after the expiry date.
Întrebări frecvente
What’s the difference between Roliten (IR) and Terol LA (extended-release)?
Same active ingredient (tolterodine tartrate), different release profile. Roliten 1 mg twice daily uses immediate-release tablets — cheaper, more flexible dose adjustment, but plasma peaks-and-troughs cause more variable side effects. Terol LA 4 mg once daily uses an extended-release capsule — flatter plasma curve translates into modestly less dry mouth, simpler regimen (better adherence). Choose IR if you need finer dose titration or are titrating cautiously; switch to LA when you find a stable dose.
Why does tolterodine cause dry mouth?
Tolterodine blocks the M3 muscarinic receptors that drive saliva production — the same receptor it blocks in the bladder. Side-effect mitigation: sugar-free chewing gum, frequent sips of water, saliva substitute (Biotene). If dry mouth is intolerable, mirabegron (Mirago) avoids the antimuscarinic mechanism altogether.
How long until tolterodine works?
Initial improvement in urgency and frequency is typically noticeable within 1-2 weeks; full effect over 4-8 weeks. If no benefit by 8 weeks at the maximum tolerated dose, switching to a different OAB drug (mirabegron, solifenacin) is reasonable.
Can I take tolterodine if I am over 65?
The 2023 American Geriatrics Society Beers Criteria classifies all anticholinergic OAB drugs as “potentially inappropriate” in older adults. Tolterodine is somewhat better tolerated than oxybutynin but still carries the anticholinergic burden risk — falls, cognitive slowing, possible long-term dementia association. Discuss mirabegron first with your doctor; it has equivalent efficacy without these risks.
Can I take tolterodine with mirabegron?
Yes — combination therapy with a low-dose anticholinergic plus mirabegron is well-evidenced for refractory OAB symptoms (BESIDE-style data). Monitor for urinary retention, particularly in men with bladder outlet obstruction.
Will tolterodine affect my driving or work?
Drowsiness, dizziness, and blurred vision can affect driving or operating machinery. Avoid until you know how the medication affects you. Effects typically settle after the first 1-2 weeks.
Where can I order Roliten online?
You can order Roliten from MedsBase in standard pack sizes. Orders ship worldwide with discreet packaging. Tolterodine is specialist-supervised worldwide.
Alternative conexe
Alte produse din Sănătate generală pe care clienții le vizualizează de asemenea:
Mai multe opțiuni în vezică și prostată
Clasificate în funcție de volumul recent de comenzi MedsBase — ce aleg alți clienți în această categorie.
| Concentrație | 1 mg |
|---|---|
| Cantitate | 30 Comprimat/e, 60 Comprimat/e, 90 Comprimat/e, 180 Comprimat/e |
Roliten
Întrebări și răspunsuri
Roliten
Produse similare
Recenzii
Nu există recenzii încă